Transforming growth factor-beta differently regulates urokinase type plasminogen activator and matrix metalloproteinase-9 expression in mouse macrophages; analysis of intracellular signal transduction

Cell Biology International

Volumn 39, Issue 5, 2015, Pages 619-628

  Mojsilović, Sonja S ^a   Santibanez, Juan F ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Macrophage; Matrix metalloproteinase 9; Signal transduction; Transforming growth factor beta; Urokinase type plasminogen activator

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JNK1 PROTEIN; JNK2 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 6; SMAD PROTEIN; SMAD3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UROKINASE; MMP9 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME REGULATION; INTRACELLULAR SIGNALING; MACROPHAGE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

MURINAE;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84927788243     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10435     Document Type: Article

References (45)

1. Bierie B, Moses HL ( 2006) TGF-β and cancer. Cytokine Growth Factor Rev 17:29-40.
2. Bonizzi G, Karin M ( 2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25:280-8.
3. Carmeli E, Moas M, Reznick AZ, Coleman R ( 2004) Matrix metalloproteinases and skeletal muscle: a brief review. Muscle Nerve 29:191-7.
4. Cho KY, Miyoshi H, Kuroda S, Yasuda H, Kamiyama K, Nakagawara J, Takigami M, Kondo T, Atsumi T ( 2013) The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery. J Stroke Cerebrovasc Dis 22:910-8.
5. Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Garcia M ( 1993) Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor. J Cell Physiol 155:595-60.
6. Falcone DJ, McCaffrey TA, Mathew J, McAdam K, Borth W ( 1995) THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor. J Cell Physiol 164:334-43.
7. Getts DR, Terry RL, Getts MT, Deffrasnes C, Muller M, van Vreden C, Ashhurst TM, Chami B, McCarthy D, Wu H, Ma J, Martin A, Shae LD, Witting P, Kansas GS, Kuhn J, Hafezi W, Campbell IL, Reilly D, Say J, Brown L, White MY, Cordwell SJ, Chadban SJ, Thorp EB, Bao S, Miller SD, King NJ ( 2014) Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Sci Transl Med 6:219ra7.
8. Gigante M, Gesualdo L, Ranieri E ( 2012) TGF-beta: a master switch in tumor immunity. Curr Pharm Des 18:4126-34.
9. Gong Y, Hart E, Shchurin A, Hoover-Plow J ( 2008) Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest 118:3012-20.
10. Han MS, Jung DY, Morel C, Lakhani SA, Kim JK, Flavell RA, Davis RJ ( 2013) JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 339:218-22.
11. Hao NB, Lu MH, Fan YH, Cao YL, Zhang ZR, Yang SM ( 2012) Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012:948098.
12. Hildenbrand R, Jansen C, Wolf G, Böhme B, Berger S, von Minckwitz G, Hörlin A, Kaufmann M, Stutte HJ ( 1998) Transforming growth factor-beta stimulates urokinase expression in tumor-associated macrophages of the breast. Lab Invest 78:59-71.
13. Hindi SM, Shin J, Ogura Y, Li H, Kumar A ( 2013) Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice. PLoS One 8:e72121.
14. Jeon SH, Chae BC, Kim HA, Seo GY, Seo DW, Chun GT, Kim NS, Yie SW, Byeon WH, Eom SH, Ha KS, Kim YM, Kim PH ( 2007) Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J Leukoc Biol 81:557-66.
15. Kawao N, Nagai N, Tamura Y, Horiuchi Y, Okumoto K, Okada K, Suzuki Y, Umemura K, Yano M, Ueshima S, Kaji H, Matsuo O ( 2012) Urokinase-type plasminogen activator and plasminogen mediate activation of macrophage phagocytosis during liver repair in vivo. Thromb Haemost 107:749-59.
16. Kluger MA, Zahner G, Paust HJ, Schaper M, Magnus T, Panzer U, Stahl RA ( 2013) Leukocyte-derived MMP9 is crucial for the recruitment of proinflammatory macrophages in experimental glomerulonephritis. Kidney Int 83:865-77.
17. Kocic J, Santibanez JF, Krstic A, Mojsilovic S, Ilic V, Bugarski D ( 2013) Interleukin-17 modulates myoblast cell migration by inhibiting urokinase type plasminogen activator expression through p38 mitogen-activated protein kinase. Int J Biochem Cell Biol 45:464-75.
18. Krstic J, Santibanez JF ( 2014) Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells. SWJ 2014:521754.
19. Lee YS, Lan Tran HT, Van Ta Q ( 2009) Regulation of expression of matrix metalloproteinase-9 by JNK in Raw 264. 7 cells: presence of inhibitory factor(s) suppressing MMP-9 induction in serum and conditioned media. Exp Mol Med 41:259-68.
20. Leifler KS, Svensson S, Abrahamsson A, Bendrik C, Robertson J, Gauldie J, Olsson AK, Dabrosin C ( 2013) Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer. J Immunol 190:4420-30.
21. Liguori M, Solinas G, Germano G, Mantovani A, Allavena P ( 2011) Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma. Cancers 3:3740-61.
22. Mantovani A, Allavena P, Sica A, Balkwill F ( 2008) Cancer-related inflammation. Nature 454:436-44.
23. Mantovani A, Sica A ( 2010) Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22:231-7.
24. Matsumura S, Iwanaga S, Mochizuki S, Okamoto H, Ogawa S, Okada Y ( 2005) Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest 115:599-60.
25. Mercurio F, DiDonato JA, Rosette C, Karin M ( 1993) P105 and p98 precursor proteins play an active role in NF-kB-mediated signal transduction. Genes Dev 7:705-18.
26. Meznarich J, Malchodi L, Helterline D, Ramsey SA, Bertko K, Plummer T, Plawman A, Gold E, Stempien-Otero A ( 2013) Urokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophages. PLoS One 8:e57837.
27. Novak ML, Bryer SC, Cheng M, Nguyen MH, Conley KL, Cunningham AK, Xue B, Sisson TH, You JS, Hornberger TA, Koh TJ ( 2011) Macrophage-specific expression of urokinase-type plasminogen activator promotes skeletal muscle regeneration. J Immunol 187:1448-57.
28. Ogawa K, Chen F, Kuang C, Chen Y ( 2004) Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site. Biochem J 381:413-22.
29. Ogawa K, Funaba M, Tsujimoto M ( 2011) The effects of TGF-β1 on the expression of type IV collagenases in mouse peritoneal macrophages. Mol Biol Rep 38:1451-6.
30. Padua D, Massagué J ( 2009) Roles of TGFβ in metastasis. Cell Res 19:89-102.
31. Parks WC, Wilson CL, Lopez-Boado YS ( 2004) Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4:617-29.
32. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D, Dieli F, Ghisletti S, Natoli G, De Baetselier P, Mantovani A, Sica A ( 2009) Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. PNAS 106:14978-83.
33. Raschke WC, Baird S, Ralph P, Nakoinz I ( 1978) Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15:261-7.
34. Sánchez-Tilló E, Comalada M, Xaus J, Farrera C, Valledor AF, Caelles C, Lloberas J, Celada A ( 2007) JNK1 is required for the induction of Mkp1 expression in macrophages during proliferation and lipopolysaccharide-dependent activation. J Biol Chem 282:12566-73.
35. Santibanez JF, Kocic J, Fabra A, Cano A, Quintanilla M ( 2010) Rac1 modulates TGF-beta1-mediated epithelial cell plasticity and MMP9 production in transformed keratinocytes. FEBS Lett 584:2305-10.
36. Santibanez JF ( 2013) Transforming growth factor-beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis - implications in skin cancer. Dermatology 2013:597927.
37. Savinova OV, Hoffmann A, Ghosh G ( 2009) The NFkb1 and NFkb2 proteins p105 and p100 function as the core of high-molecular-weight heterogeneous complexes. Molecular Cell 34:591-602.
38. Ulisse S, Baldini E, Sorrenti S, D'Armiento M ( 2009) The urokinase plasminogen activator system: a target for anti-cancer therapy. Curr Cancer Drug Targets 9:32-71.
39. Van Goethem E, Poincloux R, Gauffre F, Maridonneau-Parini I, Le Cabec V ( 2010) Matrix architecture dictates three-dimensional migration modes of human macrophages: differential involvement of proteases and podosome-like structures. J Immunol 184:1049-61.
40. Vérollet C, Charrière GM, Labrousse A, Cougoule C, Le Cabec, V, Maridonneau-Parini I ( 2011) Extracellular proteolysis in macrophage migration: losing grip for a breakthrough. Eur J Immunol 41:2805-13.
41. Villar V, Kocic J, Santibanez JF ( 2010) Spred2 inhibits TGF-β1-induced urokinase type plasminogen activator expression, cell motility and epithelial mesenchymal transition. Int J Cancer 127:77-85.
42. Xie B, Dong Z, Fidler IJ ( 1994) Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. J Immunol 152:3637-44.
43. Yang L, Pang Y, Moses HL ( 2010) TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol 31:220-7.
44. Zhang F, Banker G, Liu X, Suwanabol PA, Lengfeld J, Yamanouchi D, Kent KC, Liu B ( 2011) The novel function of advanced glycation end products in regulation of MMP-9 production. J Surg Res 171:871-6.
45. Zhang J, Sud S, Mizutani K, Gyetko MR, Pienta KJ ( 2011) Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model. Neoplasia 13:23-30.